3.
Results of health economic evaluation
| Screening group | Cost-effectiveness (RMB/LYS) | Cost-utility (RMB/QALY) | Cost-benefit |
| LBC, liquid-based cytology; HPV, human papillomavirus; LYS, life year saved; QALY, quality-adjusted life year. | |||
| LBC | |||
| Every 3 years | 51,421.13 | 14,633.30 | 5.00 |
| HPV | |||
| Every 3 years | 59,191.55 | 15,425.69 | 4.70 |
| Every 5 years | 44,971.21 | 12,174.41 | 6.21 |
| HPV+LBC | |||
| Every 3 years | 79,252.94 | 22,417.89 | 3.42 |
| Every 5 years | 64,250.21 | 18,709.44 | 4.28 |